OLR1 and lung carcinoma: Condamine et al. examined the distinctions between low-density polymorphonuclear MDSCs (PMN-MDSCs) and high-density neutrophils from head and neck cancer and lung cancer patients, identifying Lectin-type oxidized LDL receptor-1(LOX-1) as a discriminative marker for PMN-MDSCs [8].